332 related articles for article (PubMed ID: 9232944)
1. Advances in the treatment of superficial fungal infections: focus on onychomycosis and dry tinea pedis.
Del Rosso JQ
J Am Osteopath Assoc; 1997 Jun; 97(6):339-46. PubMed ID: 9232944
[TBL] [Abstract][Full Text] [Related]
2. Terbinafine. An update of its use in superficial mycoses.
McClellan KJ; Wiseman LR; Markham A
Drugs; 1999 Jul; 58(1):179-202. PubMed ID: 10439936
[TBL] [Abstract][Full Text] [Related]
3. Itraconazole and terbinafine in perspective. From petri dish to patient.
De Doncker P; Gupta AK
Postgrad Med; 1999 Jul; Spec No():6-11. PubMed ID: 10492660
[TBL] [Abstract][Full Text] [Related]
4. A risk-benefit assessment of the newer oral antifungal agents used to treat onychomycosis.
Gupta AK; Shear NH
Drug Saf; 2000 Jan; 22(1):33-52. PubMed ID: 10647975
[TBL] [Abstract][Full Text] [Related]
5. Dermatophytosis: the management of fungal infections.
Gupta AK; Ryder JE; Chow M; Cooper EA
Skinmed; 2005; 4(5):305-10. PubMed ID: 16282753
[TBL] [Abstract][Full Text] [Related]
6. Common fungal infections of the feet in patients with diabetes mellitus.
Tan JS; Joseph WS
Drugs Aging; 2004; 21(2):101-12. PubMed ID: 14960127
[TBL] [Abstract][Full Text] [Related]
7. Treatment of onychomycosis and tinea pedis with intermittent itraconazole therapy.
Del Rosso JQ
J Am Osteopath Assoc; 1996 Oct; 96(10):607-9. PubMed ID: 8936929
[TBL] [Abstract][Full Text] [Related]
8. The use of itraconazole to treat cutaneous fungal infections in children.
Gupta AK; Nolting S; de Prost Y; Delescluse J; Degreef H; Theissen U; Wallace R; Marynissen G; De Doncker P
Dermatology; 1999; 199(3):248-52. PubMed ID: 10592406
[TBL] [Abstract][Full Text] [Related]
9. Superficial fungus infections.
Stone OJ; Westburg SP
Am Fam Physician; 1974 Jan; 9(1):163-72. PubMed ID: 4272311
[No Abstract] [Full Text] [Related]
10. Terbinafine: an oral and topical antifungal agent.
Shear NH; Villars VV; Marsolais C
Clin Dermatol; 1991; 9(4):487-95. PubMed ID: 1840406
[No Abstract] [Full Text] [Related]
11. The use of systemic antimycotics in dermatotherapy.
Niewerth M; Korting HC
Eur J Dermatol; 2000 Mar; 10(2):155-60. PubMed ID: 10694319
[TBL] [Abstract][Full Text] [Related]
12. Diagnosing and treating onychomycosis.
Zaias N; Glick B; Rebell G
J Fam Pract; 1996 May; 42(5):513-8. PubMed ID: 8642370
[TBL] [Abstract][Full Text] [Related]
13. [Terbinafine (Lamisil)].
Breton MC
Union Med Can; 1995 Nov; 124(3):20-5. PubMed ID: 8560634
[No Abstract] [Full Text] [Related]
14. The significance of itraconazole for treatment of fungal infections of skin, nails and mucous membranes.
Korting HC; Schöllmann C
J Dtsch Dermatol Ges; 2009 Jan; 7(1):11-9, 11-20. PubMed ID: 18479501
[TBL] [Abstract][Full Text] [Related]
15. The use of oral antifungal agents to treat onychomycosis.
Gupta AK; Ryder JE
Dermatol Clin; 2003 Jul; 21(3):469-79, vi. PubMed ID: 12956199
[TBL] [Abstract][Full Text] [Related]
16. Itraconazole and terbinafine in perspective: from petri dish to patient.
De Doncker P
J Eur Acad Dermatol Venereol; 1999 Sep; 12 Suppl 1():S10-6; discussion S17. PubMed ID: 10509936
[TBL] [Abstract][Full Text] [Related]
17. Role of oral antifungal agents for the treatment of superficial fungal infections in immunocompromised patients.
Millikan LE
Cutis; 2001 Jul; 68(1 Suppl):6-14. PubMed ID: 11499333
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of itraconazole, terbinafine, fluconazole, griseofulvin and ketoconazole in the treatment of Scopulariopsis brevicaulis causing onychomycosis of the toes.
Gupta AK; Gregurek-Novak T
Dermatology; 2001; 202(3):235-8. PubMed ID: 11385230
[TBL] [Abstract][Full Text] [Related]
19. Management of mycoses in daily practice.
Drago L; Micali G; Papini M; Piraccini BM; Veraldi S
G Ital Dermatol Venereol; 2017 Dec; 152(6):642-650. PubMed ID: 29050446
[TBL] [Abstract][Full Text] [Related]
20. The new oral antifungal agents for onychomycosis of the toenails.
Gupta AK; Shear NH
J Eur Acad Dermatol Venereol; 1999 Jul; 13(1):1-13. PubMed ID: 10565624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
